BioCentury
ARTICLE | Company News

Diamyd Medical, University of Michigan, University of Pittsburgh deal

April 6, 2009 7:00 AM UTC

Diamyd received exclusive, worldwide rights to the universities' technology for in vivo biosynthesis and delivery of carboxy-amidated peptides. The technology was co-discovered by the universities and...